HUSCAP logo Hokkaido Univ. logo

Hokkaido University Collection of Scholarly and Academic Papers >
Faculty of Pharmaceutical Sciences >
Peer-reviewed Journal Articles, etc >

Mitochondrial drug delivery systems for macromolecule and their therapeutic application to mitochondrial diseases

Files in This Item:
YamadaYuma_HUS2011-3 [ADDR].pdf4.14 MBPDFView/Open
Please use this identifier to cite or link to this item:http://hdl.handle.net/2115/45407

Title: Mitochondrial drug delivery systems for macromolecule and their therapeutic application to mitochondrial diseases
Authors: Yamada, Yuma Browse this author
Harashima, Hideyoshi Browse this author
Keywords: Mitochondria
mitochondrial drug delivery
mitochondrial macromolecule delivery
MITO-Porter
membrane fusion
multifunctional envelope-type nano device (MEND)
mitochondrial protein therapy
mitochondrial gene therapy
mitochondrial protein import machinery
mitochondrial DNA
Issue Date: Nov-2008
Publisher: Elsevier
Journal Title: Advanced Drug Delivery Reviews
Volume: 60
Issue: 13-14
Start Page: 1439
End Page: 1462
Publisher DOI: 10.1016/j.addr.2008.04.016
PMID: 18655816
Abstract: Mitochondrial dysfunction has been implicated in a variety of human disorders—the so-called mitochondrial diseases. Therefore, the organelle is a promising therapeutic drug target. In this review, we describe the key role of mitochondria in living cells, a number of mitochondrial drug delivery systems and mitochondria-targeted therapeutic strategies. In particular, we discuss mitochondrial delivery of macromolecules, such as proteins and nucleic acids. The discussion of protein delivery is limited primarily to the mitochondrial import machinery. In the section on mitochondrial gene delivery and therapy, we discuss mitochondrial diseases caused by mutations in mitochondrial DNA, several gene delivery strategies and approaches to mitochondrial gene therapy. This review also summarizes our current efforts regarding liposome-based delivery system including use of a multifunctional envelope-type nano device (MEND) and mitochondrial liposome-based delivery as anti-cancer therapies. Furthermore, we introduce the novel MITO-Porter—a liposome-based mitochondrial delivery system that functions using a membrane-fusion mechanism.
Relation: http://www.sciencedirect.com/science/journal/0169409X
Type: article (author version)
URI: http://hdl.handle.net/2115/45407
Appears in Collections:薬学研究院 (Faculty of Pharmaceutical Sciences) > 雑誌発表論文等 (Peer-reviewed Journal Articles, etc)

Submitter: 山田 勇磨

Export metadata:

OAI-PMH ( junii2 , jpcoar )

MathJax is now OFF:


 

 - Hokkaido University